$SCYX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCYNEXIS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SCYNEXIS INC. Get notifications about new insider transactions in SCYNEXIS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 09 2014 | SCYX | SCYNEXIS INC | F.C.P.R. Genavent | 10% Owner | Buy | C | 0.00 | 96,921 | 0 | 164,036 | 67.1 K to 164 K (+144.41 %) |
| May 09 2014 | SCYX | SCYNEXIS INC | F.C.P.R. Genavent | 10% Owner | Buy | C | 0.00 | 53,112 | 0 | 67,115 | 14 K to 67.1 K (+379.29 %) |
| May 09 2014 | SCYX | SCYNEXIS INC | F.C.P.R. Genavent | 10% Owner | Buy | X | 0.20 | 3,501 | 700 | 14,003 | 10.5 K to 14 K (+33.34 %) |
| May 09 2014 | SCYX | SCYNEXIS INC | F.C.P.R. Genavent | 10% Owner | Buy | X | 0.20 | 5,251 | 1,050 | 10,502 | 5.3 K to 10.5 K (+100.00 %) |
| May 09 2014 | SCYX | SCYNEXIS INC | F.C.P.R. Genavent | 10% Owner | Buy | X | 0.20 | 5,251 | 1,050 | 5,251 | 0 to 5.3 K |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | C | 0.00 | 623,880 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | C | 0.00 | 863,672 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | C | 0.00 | 313,996 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | C | 0.00 | 166,482 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | X | 0.20 | 25,998 | 5,200 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | X | 0.20 | 5,251 | 1,050 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Option Exercise | X | 0.20 | 5,251 | 1,050 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | P | 10.00 | 50,000 | 500,000 | 295,077 | 245.1 K to 295.1 K (+20.40 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | C | 0.00 | 30,582 | 0 | 245,077 | 214.5 K to 245.1 K (+14.26 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | C | 0.00 | 42,336 | 0 | 214,495 | 172.2 K to 214.5 K (+24.59 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | C | 0.00 | 88,796 | 0 | 172,159 | 83.4 K to 172.2 K (+106.52 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | C | 0.00 | 46,863 | 0 | 83,363 | 36.5 K to 83.4 K (+128.39 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | X | 0.20 | 25,998 | 5,200 | 36,500 | 10.5 K to 36.5 K (+247.55 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | X | 0.20 | 5,251 | 1,050 | 10,502 | 5.3 K to 10.5 K (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | FCPR Biotechnology Fund | 10% Owner | Buy | X | 0.20 | 5,251 | 1,050 | 5,251 | 0 to 5.3 K |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Option Exercise | C | 0.00 | 1,665 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Option Exercise | C | 0.00 | 8,127 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Option Exercise | X | 0.20 | 222 | 44 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Option Exercise | X | 0.20 | 34 | 7 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Option Exercise | X | 0.20 | 34 | 7 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Buy | C | 0.00 | 81 | 0 | 4,507 | 4.4 K to 4.5 K (+1.83 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Buy | C | 0.00 | 398 | 0 | 4,426 | 4 K to 4.4 K (+9.88 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Buy | X | 0.20 | 222 | 44 | 4,028 | 3.8 K to 4 K (+5.83 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Buy | X | 0.20 | 34 | 7 | 3,806 | 3.8 K to 3.8 K (+0.90 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Arthaud Laurent | Director | Buy | X | 0.20 | 34 | 7 | 3,772 | 3.7 K to 3.8 K (+0.91 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | C | 0.00 | 623,880 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | C | 0.00 | 863,672 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | C | 0.00 | 313,996 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | C | 0.00 | 166,482 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | X | 0.20 | 25,998 | 5,200 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | X | 0.20 | 5,251 | 1,050 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Option Exercise | X | 0.20 | 5,251 | 1,050 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | P | 10.00 | 50,000 | 500,000 | 295,077 | 245.1 K to 295.1 K (+20.40 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | C | 0.00 | 30,582 | 0 | 245,077 | 214.5 K to 245.1 K (+14.26 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | C | 0.00 | 42,336 | 0 | 214,495 | 172.2 K to 214.5 K (+24.59 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | C | 0.00 | 88,796 | 0 | 172,159 | 83.4 K to 172.2 K (+106.52 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | C | 0.00 | 46,863 | 0 | 83,363 | 36.5 K to 83.4 K (+128.39 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | X | 0.20 | 25,998 | 5,200 | 36,500 | 10.5 K to 36.5 K (+247.55 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | X | 0.20 | 5,251 | 1,050 | 10,502 | 5.3 K to 10.5 K (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Nothias Jean-Yves | Director | Buy | X | 0.20 | 5,251 | 1,050 | 5,251 | 0 to 5.3 K |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 53,915 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 37,702 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 20,975 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 3,033 | 607 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 174 | 35 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 174 | 35 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 1,417,315 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 1,024,876 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | C | 0.00 | 570,159 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 82,454 | 16,491 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 4,551 | 910 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Option Exercise | X | 0.20 | 4,551 | 910 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | P | 10.00 | 31,934 | 319,340 | 45,736 | 13.8 K to 45.7 K (+231.37 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 2,642 | 0 | 13,802 | 11.2 K to 13.8 K (+23.67 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 1,848 | 0 | 11,160 | 9.3 K to 11.2 K (+19.85 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 5,931 | 0 | 9,312 | 3.4 K to 9.3 K (+175.42 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 3,033 | 607 | 3,381 | 348 to 3.4 K (+871.55 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 174 | 35 | 348 | 174 to 348 (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 174 | 35 | 174 | 0 to 174 |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | P | 10.00 | 868,066 | 8,680,660 | 1,240,575 | 372.5 K to 1.2 M (+233.03 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 69,476 | 0 | 372,509 | 303 K to 372.5 K (+22.93 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 50,239 | 0 | 303,033 | 252.8 K to 303 K (+19.87 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | C | 0.00 | 161,238 | 0 | 252,794 | 91.6 K to 252.8 K (+176.11 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 82,454 | 16,491 | 91,556 | 9.1 K to 91.6 K (+905.89 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 4,551 | 910 | 9,102 | 4.6 K to 9.1 K (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | ALTA BIOPHARMA PARTNERS II LP | 10% Owner | Buy | X | 0.20 | 4,551 | 910 | 4,551 | 0 to 4.6 K |
| May 08 2014 | SCYX | SCYNEXIS INC | KIRBY PAMELA J | Director | Option Exercise | C | 0.00 | 260,000 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | KIRBY PAMELA J | Director | Option Exercise | X | 0.20 | 12,745 | 2,549 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | KIRBY PAMELA J | Director | Buy | C | 0.00 | 12,745 | 0 | 25,590 | 12.8 K to 25.6 K (+99.22 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | KIRBY PAMELA J | Director | Buy | X | 0.20 | 12,745 | 2,549 | 12,745 | 0 to 12.7 K |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | C | 0.00 | 3,010,807 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | C | 0.00 | 809,584 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | C | 0.00 | 340,509 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | C | 0.00 | 109,879 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | X | 0.20 | 43,704 | 8,741 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | X | 0.20 | 14,005 | 2,801 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Option Exercise | X | 0.20 | 14,005 | 2,801 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | P | 10.00 | 28,000 | 280,000 | 414,211 | 386.2 K to 414.2 K (+7.25 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | C | 0.00 | 147,588 | 0 | 386,211 | 238.6 K to 386.2 K (+61.85 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | C | 0.00 | 39,685 | 0 | 238,623 | 198.9 K to 238.6 K (+19.95 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | C | 0.00 | 96,294 | 0 | 198,938 | 102.6 K to 198.9 K (+93.81 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | C | 0.00 | 30,930 | 0 | 102,644 | 71.7 K to 102.6 K (+43.13 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | X | 0.20 | 43,704 | 8,741 | 71,714 | 28 K to 71.7 K (+156.03 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | X | 0.20 | 14,005 | 2,801 | 28,010 | 14 K to 28 K (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ventech Capital II | 10% Owner | Buy | X | 0.20 | 14,005 | 2,801 | 14,005 | 0 to 14 K |
| May 08 2014 | SCYX | SCYNEXIS INC | Ribeill Yves J | President and CEO | Option Exercise | C | 0.00 | 12,142 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ribeill Yves J | President and CEO | Option Exercise | X | 0.20 | 595 | 119 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Ribeill Yves J | President and CEO | Buy | C | 0.00 | 595 | 0 | 1,190 | 595 to 1.2 K (+100.00 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Ribeill Yves J | President and CEO | Buy | X | 0.20 | 595 | 119 | 595 | 0 to 595 |
| May 08 2014 | SCYX | SCYNEXIS INC | Langlois Patrick | Director | Option Exercise | C | 0.00 | 107,142 | 0 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Langlois Patrick | Director | Option Exercise | X | 0.20 | 5,251 | 1,050 | 0 | |
| May 08 2014 | SCYX | SCYNEXIS INC | Langlois Patrick | Director | Buy | C | 0.00 | 5,252 | 0 | 10,503 | 5.3 K to 10.5 K (+100.02 %) |
| May 08 2014 | SCYX | SCYNEXIS INC | Langlois Patrick | Director | Buy | X | 0.20 | 5,251 | 1,050 | 26,785 | 21.5 K to 26.8 K (+24.38 %) |